“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
This significant milestone includes more than 6 million of Alcon’s latest-generation of presbyopia-correcting IOLs (PCIOLs) that have been implanted globally, helping patients attain greater visual ...
FORT WORTH, Texas--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof ® IQ Vivity ® and Clareon ® Vivity ...
Alcon’s leading position in phacoemulsification for cataract surgery, with a 50% market share, helps pull in demand for standard intraocular lenses, or IOL, from bundling, and Alcon now holds a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results